PMGC Holdings Inc. (NASDAQ:ELAB) Short Interest Up 63.2% in May
by Sarita Garza · The Markets DailyPMGC Holdings Inc. (NASDAQ:ELAB – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 385,403 shares, a growth of 63.2% from the April 30th total of 236,186 shares. Currently, 33.3% of the shares of the company are short sold. Based on an average daily volume of 733,200 shares, the short-interest ratio is currently 0.5 days.
PMGC Stock Performance
NASDAQ:ELAB traded down $0.05 during mid-day trading on Thursday, hitting $1.76. 150,774 shares of the company’s stock traded hands, compared to its average volume of 4,684,749. The firm has a market capitalization of $2.05 million, a price-to-earnings ratio of -0.01 and a beta of -0.27. The firm has a 50 day moving average of $3.05 and a two-hundred day moving average of $28.74. The company has a current ratio of 1.45, a quick ratio of 1.43 and a debt-to-equity ratio of 0.03. PMGC has a 12 month low of $1.62 and a 12 month high of $309.12.
PMGC (NASDAQ:ELAB – Get Free Report) last issued its quarterly earnings results on Thursday, May 14th. The company reported ($11.22) EPS for the quarter. The firm had revenue of $0.68 million during the quarter.
PMGC Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.